Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Caliper Partners with Catholic Health Initiatives to Augment Methods for Testing Anticancer Candidates

CDAS will look for biomarkers and conduct drug resistance and sensitivity studies on human samples provided by CTR.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »